|
|
|
|
3 | (16) |
|
|
|
|
19 | (20) |
|
|
|
|
39 | (6) |
|
|
|
|
|
45 | (6) |
|
|
|
|
|
|
51 | (4) |
|
|
|
|
|
55 | (10) |
|
|
|
|
65 | (10) |
|
|
|
|
|
75 | (10) |
|
|
|
85 | (4) |
|
|
|
|
|
89 | (4) |
|
|
|
|
93 | (8) |
|
|
|
|
|
|
12 Iodinated Contrast Agents |
|
|
101 | (10) |
|
|
|
13 Gadolinium-Based Contrast Agents |
|
|
111 | (6) |
|
|
|
|
117 | (4) |
|
|
|
15 Pantopaque (Myodil, Iodophenylundecylic Acid) |
|
|
121 | (8) |
|
|
16 Thorium Dioxide (Thorotrast) |
|
|
129 | (6) |
|
|
|
|
17 Temozolamide (Temodar) |
|
|
135 | (6) |
|
|
|
18 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) |
|
|
141 | (8) |
|
|
|
149 | (14) |
|
|
|
163 | (4) |
|
|
21 L-Asparaginase (Elspar/Erwinase) |
|
|
167 | (6) |
|
|
|
22 Calcineurin Inhibitors |
|
|
173 | (12) |
|
|
|
23 Bromocriptine (Parlodel) and Cabergoline (Dostinex) |
|
|
185 | (8) |
|
|
24 HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) |
|
|
193 | (6) |
|
|
Part IV Anti-Cancer Immunotherapy |
|
|
|
25 Ipilimumab (MDX-010, Yervoy) |
|
|
199 | (8) |
|
|
|
|
207 | (8) |
|
|
|
27 Chimeric Antigen Receptor T-Cell Therapy (Tisagenlecleucel and Axicabtagene Ciloleucel) |
|
|
215 | (4) |
|
|
Part V Antibiotics, Antiviral Agents, and Vaccines |
|
|
|
28 Metronidazole (Flagyl) |
|
|
219 | (6) |
|
|
|
225 | (2) |
|
|
|
227 | (2) |
|
|
|
31 Highly Active Antiretroviral Therapy (HAART) |
|
|
229 | (10) |
|
|
|
|
239 | (8) |
|
|
Part VI Antiepilectic, Antipsychotic, and General Anesthetic Agents |
|
|
|
33 Dilantin (Phenytoin Sodium) |
|
|
247 | (6) |
|
|
|
34 Valproic Acid (Sodium Valproate, Depakote) |
|
|
253 | (4) |
|
|
|
257 | (4) |
|
|
|
261 | (4) |
|
|
|
|
|
265 | (6) |
|
|
|
Part VII Anesthetic and Sedative Agents |
|
|
|
38 Barbiturates (Pentobarbital) |
|
|
271 | (4) |
|
|
|
|
275 | (6) |
|
|
|
281 | (6) |
|
|
|
|
Part VIII Hemostatic and Vasoactive Agents |
|
|
|
|
287 | (10) |
|
|
|
|
42 Aspirin and Plavix/Clopidogrel |
|
|
297 | (8) |
|
|
|
|
|
305 | (8) |
|
|
|
|
|
313 | (4) |
|
|
|
|
45 Tissue Plasminogen Activator (tPA) |
|
|
317 | (4) |
|
|
|
|
|
321 | (4) |
|
|
|
325 | (6) |
|
|
Part IX Cardiovascular Support Agents |
|
|
|
|
331 | (8) |
|
|
|
339 | (6) |
|
|
50 Mannitol(1,2,3,4,5,6-Hexanehexol) |
|
|
345 | (4) |
|
|
|
349 | (4) |
|
|
52 Angiotensin-Converting Enzyme (ACE) Inhibitors |
|
|
353 | (6) |
|
|
|
53 Acetazolamide (Diamox) |
|
|
359 | (4) |
|
|
|
|
|
|
363 | (6) |
|
|
Part X Anti-Inflammatory Agents |
|
|
|
55 Acetominophen (Tylenol, Paracetamol) |
|
|
369 | (6) |
|
|
56 Natalizumab (Tysabri, Biogen Idee and Elan Pharmaceuticals) |
|
|
375 | (6) |
|
|
|
57 Synthetic Corticosteroids |
|
|
381 | (12) |
|
|
|
|
Part XI Dietary Supplements, Homeostatic Agents, and Hormone-Like Drugs |
|
|
|
58 Manganese in Total Parenteral Nutrition |
|
|
393 | (6) |
|
|
|
399 | (4) |
|
|
|
|
403 | (4) |
|
|
|
|
|
407 | (8) |
|
|
|
|
62 Recombinant Human Bone Morphogenetic Protein |
|
|
415 | (4) |
|
|
|
|
63 Retinoids (13-Cis-Retinoic Acid, Isotretinoin, Accutane, AH-Trans-Retinoic Acid) |
|
|
419 | (4) |
|
|
64 Topical Prostaglandin Analogs |
|
|
423 | (4) |
|
|
|
65 Oral Contraceptives (Estrogen and Progestin) |
|
|
427 | (6) |
|
|
|
|
|
433 | (4) |
|
|
Part XII Injectable Filler Agents |
|
|
|
67 Calcium Hydroxyapatite-Based Fillers |
|
|
437 | (4) |
|
|
68 Hyaluronic Acid-Based Fillers |
|
|
441 | (4) |
|
|
|
69 Injectable Silicone Oil |
|
|
445 | |
|
|